Loading clinical trials...
Loading clinical trials...
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Camurus AB
NCT00001595 · Panhypopituitarism, Gigantism/Acromegaly, and more
NCT04837040 · Acromegaly
NCT04125836 · Acromegaly
NCT04066569 · Acromegaly
NCT05431803 · Acromegaly
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions